Join our newsletter

Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM

APILAM informs you that the personal data that you provide to us by filling in this form will be treated by APILAM as responsible for this web. The purpose of the collection and processing of personal data that we request is to manage the registration of this subscription and send periodic bulletins with information and prospective offer of products or services.

Legitimation: Consent of the interested party

As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).

The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.

You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.

You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.

Last update Jan. 18, 2021

Acne

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Trastorno cutáneo en el que hay obstrucción e inflamación de los folículos pilo-sebáceos por exceso de producción de grasa y sobreinfección bacteriana.
En el acné puede haber un exceso de andrógenos y formar parte del Síndrome del Ovario Poliquístico (SOP)

El acné puede asociarse al embarazo y al posparto y es más frecuente en primíparas (Hoefel 2020, Yang 2016, Gjerdingen 1993). Se han informado más mejorías que empeoramientos del acné durante el embarazo y el posparto y ninguna relación con la lactancia (van Pelt 1999).
El acné no contraindica lactancia en sí mismo nl lactancia empeora el acné (van Pelt 1999).

La mayoría de medicamentos, especialmente los de uso tópico, para tratar el acné son compatibles con la lactancia (Koh 2019, Murase 2015, Butler 2014, Kong 2013, Fluhr 2010

See below the information of these related products:

(Contraceptive combined Estrogen & Progestins) (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Adapalene ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Azelaic Acid ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Benzoyl Peroxide ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Cyproterone Acetate ( Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.)
Dapsone (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Doxycycline (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Erythromycin (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Glycolic Acid ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Isotretinoin ( Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.)
Laser Rays ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Melitracen Hydrochloride (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Minocycline (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Netupitant (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Nicotine Replacement Therapy (NRT) ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Polycystic Ovary Syndrome ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Salicylic Acid ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Spironolactone ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Tazarotene (Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
Tretinoin (systemic use) ( Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.)
Tretinoin (topical use) ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
Zinc (systemic administration) ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Very Low Risk

High Risk

Very High Risk

Very Low Risk

High Risk

Very High Risk

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

References

List of 10 references

Hoefel IDR, Weber MB, Manzoni APD, Lovato BH, Bonamigo RR. Striae Gravidarum, Acne, Facial Spots, and Hair Disorders: Risk Factors in a Study with 1284 Puerperal Patients. J Pregnancy. 2020 May 19;2020:8036109. Abstract
Koh YP, Tian EA, Oon HH. New changes in pregnancy and lactation labelling: Review of dermatologic drugs. Int J Womens Dermatol. 2019 May 16;5(4):216-226. Abstract Full text (link to original source)
Yang CC, Huang YT, Yu CH, Wu MC, Hsu CC, Chen W. Inflammatory facial acne during uncomplicated pregnancy and post-partum in adult women: a preliminary hospital-based prospective observational study of 35 cases from Taiwan. J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1787-1789. Abstract
Murase J. Safe Skin Care During Pregnancy and Breastfeeding. Fact Sheet. For the media. American Academy of Dermatology. 2015 Full text (link to original source) Full text (in our servers)
Butler DC, Heller MM, Murase JE. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation. J Am Acad Dermatol. 2014 Mar;70(3):417.e1-10; quiz 427. Abstract
Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. Drugs. 2013 Jun;73(8):779-87. Abstract
Fluhr JW, Degitz K. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. J Dtsch Dermatol Ges. 2010 Abstract
Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. J Dtsch Dermatol Ges. 2006 Abstract
van Pelt HP, Juhlin L. Acne conglobata after pregnancy. Acta Derm Venereol. 1999 Mar;79(2):169. No abstract available. Abstract
Gjerdingen DK, Froberg DG, Chaloner KM, McGovern PM. Changes in women's physical health during the first postpartum year. Arch Fam Med. 1993 Mar;2(3):277-83. Abstract

Total visits

24,002

Acne

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Other names

Group

References

Total visits

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?